These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16323119

  • 1. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
    Sakoulas G, Moellering RC, Eliopoulos GM.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S40-50. PubMed ID: 16323119
    [Abstract] [Full Text] [Related]

  • 2. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.
    Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC.
    Clin Infect Dis; 2004 Jun 15; 38(12):1700-5. PubMed ID: 15227615
    [Abstract] [Full Text] [Related]

  • 3. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM.
    J Antimicrob Chemother; 2006 Apr 15; 57(4):699-704. PubMed ID: 16464892
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 6. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?
    Sakoulas G, Eliopoulos GM, Moellering RC, Novick RP, Venkataraman L, Wennersten C, DeGirolami PC, Schwaber MJ, Gold HS.
    J Infect Dis; 2003 Mar 15; 187(6):929-38. PubMed ID: 12660939
    [Abstract] [Full Text] [Related]

  • 7. Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management.
    Lewis JS, Ellis MW.
    Curr Opin Infect Dis; 2007 Dec 15; 20(6):568-73. PubMed ID: 17975405
    [Abstract] [Full Text] [Related]

  • 8. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G.
    Antimicrob Agents Chemother; 2007 Sep 15; 51(9):3397-400. PubMed ID: 17591849
    [Abstract] [Full Text] [Related]

  • 9. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G.
    J Antimicrob Chemother; 2007 Jun 15; 59(6):1190-3. PubMed ID: 17434881
    [Abstract] [Full Text] [Related]

  • 10. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN.
    Clin Microbiol Infect; 2008 Mar 15; 14 Suppl 2():3-9. PubMed ID: 18226084
    [Abstract] [Full Text] [Related]

  • 11. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ, Tice A.
    Clin Infect Dis; 2010 Sep 15; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [Abstract] [Full Text] [Related]

  • 12. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
    Fowler VG, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS.
    J Infect Dis; 2004 Sep 15; 190(6):1140-9. PubMed ID: 15319865
    [Abstract] [Full Text] [Related]

  • 13. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 15; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 14. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML.
    Clin Infect Dis; 2004 Feb 01; 38(3):448-51. PubMed ID: 14727222
    [Abstract] [Full Text] [Related]

  • 15. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G, Kamath S, Hussain A.
    Indian J Pathol Microbiol; 2006 Apr 01; 49(2):311-2. PubMed ID: 16933753
    [No Abstract] [Full Text] [Related]

  • 16. Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density.
    Tsuji BT, Harigaya Y, Lesse AJ, Sakoulas G, Mylotte JM.
    Diagn Microbiol Infect Dis; 2009 Jun 01; 64(2):220-4. PubMed ID: 19345040
    [Abstract] [Full Text] [Related]

  • 17. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jul 11; 46(27):624-6. PubMed ID: 9218648
    [Abstract] [Full Text] [Related]

  • 18. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST.
    Clin Infect Dis; 2007 Sep 15; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [Abstract] [Full Text] [Related]

  • 19. Possible role of sarA in dehydroepiandrosterone-mediated increase in Staphylococcus aureus resistance to vancomycin.
    Plotkin BJ, Konaklieva M.
    Chemotherapy; 2007 Sep 15; 53(3):181-4. PubMed ID: 17356267
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG, Basuino L, Chambers HF.
    Antimicrob Agents Chemother; 2005 Aug 15; 49(8):3163-5. PubMed ID: 16048918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.